Oncology & Cancer

New computer simulation cracks mystery of cancer drug resistance

Imatinib, better known as Gleevec, was hailed as a "miracle" cancer drug when it entered the market in the early 2000s. Though it has been highly successful at treating early-stage chronic myeloid leukemia (CML)—a rare ...

Diseases, Conditions, Syndromes

Researchers discover new pathways that could help treat RNA viruses

Researchers at the University of New Hampshire have identified new pathways in an RNA-based virus where inhibitors, like medical treatments, unbind. The finding could be beneficial in understanding how these inhibitors react ...

Neuroscience

Cornell chemists show ALS is a protein aggregation disease

Using a technique that illuminates subtle changes in individual proteins, chemistry researchers at Cornell University have uncovered new insight into the underlying causes of Amyotrophic Lateral Sclerosis (ALS).

Neuroscience

System provides clear brain scans of awake, unrestrained mice

Setting a mouse free to roam might alarm most people, but not so for nuclear imaging researchers from the U.S. Department of Energy's Thomas Jefferson National Accelerator Facility, Oak Ridge National Laboratory, Johns Hopkins ...

page 1 from 2